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Abstract 
The coupling of membrane-bound receptors to transcriptional regulators and other 
effector functions is mediated by multi-domain proteins that form complex assemblies. The 
modularity of protein interactions lends itself to a rule-based description, in which species and 
reactions are generated by rules that encode the necessary context for an interaction to occur, but 
also can produce a combinatorial explosion in the number of chemical species that make up the 
signaling network.  We have shown previously that exact network reduction can be achieved 
using hierarchical control relationships between sites/domains on proteins to dissect multi-
domain proteins into sets of non-interacting sites, allowing the replacement of  each “full” 
(progenitor) protein with a set of derived auxiliary (offspring) proteins. The description of a 
network in terms of auxiliary proteins that have fewer sites than progenitor proteins often greatly 
reduces network size. We describe here a method for automating domain-oriented model 
reduction and its implementation as a module in the BioNetGen modeling package. It takes as 
input a standard BioNetGen model and automatically performs the following steps: 1) detecting 
the hierarchical control relationships between sites; 2) building up the auxiliary proteins; 3) 
generating a raw reduced model; and 4) cleaning up the raw model to provide the correct mass 
balance for each chemical species in the reduced network. We tested the performance of this 
module on models representing portions of growth factor receptor and immunoreceptor-mediated 
signaling networks, and confirmed its ability to reduce the model size and simulation cost by at 
least one or two orders of magnitude. Limitations of the current algorithm include the inability to 
reduce models based on implicit site dependencies or heterodimerization, and loss of accuracy 
when dynamics are computed stochastically. 
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1 Introduction 
1.1 Combinatorial complexity of cell signaling networks 
Many signaling proteins, such as membrane receptors and their cytoplasmic adapters, have 
multi-domain structures and display multiple docking sites that engage several downstream 
signaling proteins, thereby serving as scaffolds [1-6]. Each domain can assume multiple states, 
for instance, a docking site on a scaffold protein can be unphosphorylated and free, 
phosphorylated and free, phosphorylated and bound to a partner, which in turn can be 
unphosphorylated and free, or phosphorylated and bound to another protein or lipid, and so on. 
In general, the functional states of such multi-domain proteins will depend on the states of all 
domains of the protein. We define a microscopic model as one that explicitly represents all 
possible states of multi-domain proteins and the feasible reactions among these states. 
As an example, we consider a cell-surface receptor of the receptor tyrosine kinase (RTK) 
family. RTK’s have a modular structure that can be divided into an extracellular region, which 
contains the ligand-binding and receptor dimerization sites, and a cytoplasmic region, which has 
tyrosine kinase activity and contains phosphorylation sites with tyrosine, serine and threonine 
residues (see Fig. 1). Ligand binding activates RTKs by inducing either dimer formation (e.g., 
epidermal growth factor (EGF) receptor) or an allosteric transition (e.g., insulin receptor, IR, and 
insulin-like growth factor receptor, IGF-1R) [7, 8]. These structural transitions result in the 
activation of intrinsic tyrosine kinase activity and subsequent autophosphorylation, which 
initiates signal processing through receptor interactions with a battery of adapter and target 
proteins containing characteristic protein domains, such as Src homology (SH2 and SH3), 
phosphotyrosine binding (PTB) and pleckstrin homology (PH) domains (reviewed in [7, 9, 10]). 
These proteins, in turn, can also possess multiple domains and sites that can be phosphorylated 
by the receptor and dephosphorylated by phosphatases.  
Binding between two signal-transduction proteins often requires one of the two interacting 
sites to be phosphorylated, which imposes an ordering on phosphorylation and binding events. 
For proteins that have multiple binding sites, however, binding of other proteins at different sites 
may be independent (i.e., no interaction among binding partners) or cooperative (i.e., binding 
partners interact either positively or negatively).  Ordering is imposed on binding interactions at 
two different sites only if the cooperativity is complete, i.e. one site must be occupied for binding 
to occur at the second site or one site must not be occupied for binding to occur at a second site.  
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Thus, in most cases the presence of multiple binding sites gives rise to many different 
combinations of protein aggregates that can have a large number of different functional states.  In 
general, the number of states of an aggregate grows in a multiplicative fashion with the number 
of possible states of each site, leading to a combinatorial explosion in the total number of 
different chemical species (molecules or complexes of molecules in which each molecule is in 
distinct state) that must be included within a microscopic model.  In the conventional approach to 
modeling chemical kinetics [11], in which the concentration of each species is described by a 
separate ordinary differential equation (ODE), combinatorial complexity may generate such a 
large set of equations that simulation becomes infeasible on even the most powerful computers. 
The problem arises in models describing only the initial steps following ligand-receptor binding, 
which can lead to hundreds or thousands of possible species [12-15].  Extended models of 
growth factor receptors and their initial scaffolding partners can produce networks of 108 species 
[15], 1023 species [16], and beyond, rendering the conventional approach useless for such 
microscopic models. 
 
1.2 Domain-oriented model reduction  
One way to avoid the problem of combinatorial explosion is model reduction. It has recently 
been shown that by introducing a set of variables that tracks only subsets of the possible 
combinations of the domain/site states rather than the full set of possible complexes, it is possible 
to derive a reduced set of dynamical equations for many signaling networks [1, 2, 4, 15, 17]. This 
domain-oriented approach to model reduction is based upon the mutual independence and 
hierarchical control relationships between different sites of each protein in a network, which goes 
as follows. If the rates of transitions between the states of site qi on a protein Q depend upon the 
state of another site qj on the same protein Q, then site qi is termed dependent on site qj, and, 
respectively, site qj is referred to as a controlling site for qi [1]. The independence of sites means 
that the time course of reactions involving some sites may be decoupled from the reactions 
occurring at other sites. For each scaffold protein, called a progenitor, a set of auxiliary 
(offspring) proteins can be introduced, each of which contains a subset of the progenitor 
protein’s sites. Previous work has shown that the sites contained by the auxiliary proteins can be 
chosen so that each reacts independently of the other auxiliary proteins. The concentration of an 
auxiliary protein with sites q1…qk in states s1…sk is defined to be the sum of concentrations of 
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all forms of the scaffold protein in which each of the k sites has the same state as in the auxiliary 
protein. The concentrations of the auxiliary proteins are thus macroscopic (macro) variables that 
are comprised of sums over the concentrations of microscopic (micro) species in the system. In 
contrast to the number of micro variables, which is a multiplicative function of the number of 
states of each site, the number of macro variables is additive in the number of states of each 
auxiliary protein. If a protein contains multiple independent sites, the number of macro variables 
describing the protein’s dynamics can be much smaller than the number of micro states of the 
protein. 
The domain-oriented approach thus provides a macroscopic description of network dynamics 
in that it does not follow the fate of all species and reactions that are generated by scaffold 
signaling, thereby greatly reducing the number of states and equations required for a quantitative 
analysis of the system behavior. The ODE’s obtained by the transformation to macro variables 
are exact in terms of auxiliary proteins. Kinetic Monte Carlo methods, such as the Gillespie 
algorithm [2], can also be used to provide an exact stochastic description of the dynamics in 
terms of the macro variables, but, as we note below in Sec. 2.4 require slight modification to 
avoid loss of accuracy. The transformation to macro variables entails some loss of information 
about correlations between independent sites of a protein, but such correlations typically cannot 
be measured by available experimental techniques, most of which detect binding or 
phosphorylation at either the whole protein or the single site level.  If such data is available, the 
modeler may choose to define observables that track multiple sites within a protein, although this 
will lessen the extent to which the model can be reduced.  Multi-site observables may also be 
approximately reconstructed from single-site observables [1, 2, 4].  In practice, single-site macro 
variables are frequently sufficient for making direct comparisons with experimental 
measurements [18].  
The domain-oriented approach to model reduction can decrease the number of variables by 
orders of magnitude and thus promises to be a powerful tool for the development of realistic 
models of intracellular signaling.  Existing methods [1, 2, 4, 15, 17], however, are not automated 
and require the modeler to define manually the set of auxiliary proteins and the rules for their 
interaction.  For a highly interconnected network, this requires considerable modeling experience 
and effort and may obscure the basic structure of the model.  Moreover, the procedure has not 
yet been formalized algorithmically in the previous works that describe the principle of domain-
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oriented reduction.  In this paper, we present an algorithm for domain-oriented model reduction, 
which has been implemented as module in the freely-available BioNetGen modeling package 
[19]. 
 
 
1.3 Rule-based model description 
Recent work has shown that automated generation of domain-oriented models can be 
accomplished through the use of a rule-based model description. Several software packages, such 
as Moleculizer [20],  StochSim [21-23], BioNetGen [14, 18, 19, 24], enable the develop of rule-
based models based on a multi-state description of proteins and other signaling molecules and 
rules that transform these molecules according to specified properties of the reactants. Rules 
represent a generalization of reactions, and a single rule may be applied to many different species 
to generate new reactions and new species as products.  In order to simulate a rule-based model 
as a set of ODEs, rules are applied iteratively to a seed set of species to generate all of the 
possible reactions and species in the network [24].  The cost of network generation, as well as 
subsequent ODE integration, can be become prohibitive for models exhibiting a high degree of 
combinatorial complexity. The goal of the current algorithm is to reduce the costs of network 
generation and simulation by replacing each multi-state progenitor protein in the model with a 
set of derived auxiliary (offspring) proteins that group sets of independently-acting sites.  
Application of the transformed rules to the set of auxiliary proteins will then generate a 
transformed network that is smaller in size but no less accurate for predicting the time evolution 
of the macro variables. 
In the present paper, we will describe our domain-oriented reduction algorithm and examples 
using the specific syntax of the BioNetGen Language (BNGL), which is closely related to the κ-
calculus of Danos and co-workers [16, 25], although the method could be applied to any domain-
oriented model specification.  We have also implemented the algorithm as a module of 
BioNetGen, which is freely available from http://bionetgen.org.   A brief overview of BNGL is 
provided in the Appendix with further details provided in [19]. 
 
2 Results  
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Domain-oriented reduction attempts to construct the smallest possible model of the network 
given the molecules and interactions specified by the user that still allows correct calculation for 
the specified observables. Since the domain-oriented reduction method relies on control 
relationships between protein sites, the module should perform at least two major actions: 
(1) Construct auxiliary proteins by detecting control relationships between progenitor 
protein sites.  
(2) Generate reactions and observables for the reduced network that preserve mass 
balance.   
 
2.1 Automatic construction of auxiliary proteins 
The algorithm begins by partitioning the sites on each molecule into (possibly 
overlapping) sets based on the control hierarchy. Redundant sets are then removed, and auxiliary 
proteins based on the controlling sets are introduced.  These three steps are carried out as 
follows: 
(1) Initial determination of controlling sets. The aim of this step is to determine the 
controlling set for each site on each protein according to the reaction rules and observable 
patterns specified in the bngl-file. For each protein Q with n sites called q1, …, qn, we analyze 
the reaction rules as follows.  If there is a reaction rule in which site q1 of Q is present together 
with another site qk and the state of site q1 changes while the state of site qk does not, then site qk 
is a controlling site for q1. If q1 and qk change their states simultaneously in a reaction rule, or if 
q1 and qk are mentioned simultaneously in an observable, then sites q1 and qk are mutually 
dependent, which means that qk is considered a controlling site of q1 and vice versa.  Sites with 
identical names in the same molecule are also assumed to be mutually dependent in order to 
prevent dissection of proteins that can serve as a bridge for the formation of dimers. After 
finding all sites that control site q1, we repeat this procedure iteratively for each of the 
controlling sites found at the previous iteration until no new controlling sites can be found.  The 
set that combines the site q1 (by the definition, any site controls itself) and all direct or indirect 
controlling sites is termed a controlling set Z(Q,q1) = (q1,…,qs) for site q1 on Q. Likewise, the 
sets Z(Q,qi), i =2,…, n, are determined for each remaining site on the protein Q. All controlling 
sets Z(Q,qi) are subsets of the full set (q1,…,qn)  of sites for protein Q. The resulting sets Z(Q,qi) 
do not depend on the order of appearance of any protein, site, reaction rule, or observable in the 
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bngl-file, because the process terminates only after all possible control relationships have been 
found. 
(2) Refinement of controlling sets. The aim of the refinement step is to eliminate 
redundancy among the sets of controlling sets that are used to define the auxiliary proteins. 
Controlling sets for different sites may overlap, and if one controlling set is a subset of another it 
is removed from the set of controlling sets for a given progenitor, because an auxiliary protein 
defined from this redundant set would contain no unique information.  The controlling sets 
remaining after this refinement procedure are renumbered and designated as (Z1(Q), …, Zm(Q), 
m ≤ n). Note that after renumbering, we lose any information on the relationships between 
indexes 1, .., m used for numbering sets Zj and particular sites qi on the protein Q. The refined set 
of controlling sets is optimal as the starting point for auxiliary protein definition because it is the 
smallest set of controlling sets for the sites of Q that contains all sites of Q. 
(3) Auxiliary protein definition. For each set Zj(Q), j = 1,…, m, we define the macro 
variable [Qj(Zj(Q))], which is the sum of the concentration of protein Q(q1, …, qn) over all 
possible states of the sites that are not included in set Zj(Q). For example, if Zj(Q) contains all 
sites (q1,…,qn) except qx, qy, qz, the corresponding variable is 
[Qj(Zj(Q))] ∑∑∑
= = =
=
X
q
Y
q
Z
q
nzyx
x y z
qqqqqQ
0 0 0
1 )],...,,...,,....,,...,([ , where indices qx, qy and qz run over all 
the possible states (denoted form 0 to Z, Y and Z, respectively) of the sites qx, qy, qz, and 
[ ),...,,...,,....,,...,( 1 nzyx qqqqqQ ] is the concentration of protein Q in the state 
),...,,...,,....,,...,( 1 nzyx qqqqq . Hence, the macro variable [Qj] depends on the states of the sites 
that belong to Zj(Q) but is independent of all other sites that do not belong to Zj(Q). To 
transform the rule set defining the model from the micro variables into the macro variables, we 
define an auxiliary protein Qj for each macro variable [Qj]. The auxiliary protein Qj has a set of 
sites (Zj(Q)), which is a subset of the domains on the progenitor protein Q. In physical terms, the 
multi-state progenitor protein is replaced by a number of auxiliary proteins, each with a smaller 
number of sites.   
We can illustrate this procedure for the simple example of proteins R and B shown in 
Fig. 1.  Analysis of the reaction rules that describe binding and phosphorylation reactions that 
involve R and B (see Supplement 1) shows that on R phosphorylation residues, r3 and r4, depend 
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on the ligand-binding site, r1, as well as on the dimerization site, r2.  Likewise, on the scaffolding 
adapter protein B, the RTK-binding site b1 controls the phosphorylation residues b2 and b3.  
Controlling sets of the sites on R and B are determined by the algorithm described above as 
follows, Z(R,r1) = {r1}, Z(R,r2) = {r1,r2}, Z(R,r3) = {r1,r2,r3}, Z(R,r4) = {r1,r2,r4}, Z(B,b1) = 
{b1}, Z(B,b2) = {b1,b2}, Z(B,b3) = {b1,b3}. The deletion of redundant sets results in the following 
remaining sets, Z1(R) = {r1,r2,r3}, Z2(R) = {r1,r2,r4}, Z1(B) = {b1,b2}, Z2(B) = {b1,b3}.  
 Although it may first appear counterintuitive, the extent of model compression increases 
with the number of the auxiliary proteins derived from each protein Q, since the total number of 
micro variables is a product of the number of states of each site on Q, whereas the number of 
macro variables of is a sum of the number of states of each auxiliary protein Qj.  In the extreme 
case of interactions among all sites on the scaffold, the above procedure results in a single 
controlling set that contains every site on the protein. The resulting single auxiliary protein 
),...,( 11 nqqQQ =  is then the same as the progenitor protein, and no model reduction occurs [26]. 
 
 2.2 Generation of reactions and observables that preserve mass-balance 
Sites found on more than one auxiliary protein derived from the same progenitor protein 
are termed shared sites.  If a particular site is found on only one auxiliary protein, this site is 
referred to as a unique site.  For instance, sites r1 and r2 on the RTK R and the b1 on the adapter 
B in Fig. 1 are shared, whereas r3 and r4, b2 and b3 are unique.  The model reduction algorithm 
must ensure that proteins that bind to shared sites will not be counted more than once in mass-
balance equations.  Otherwise, the introduction of n auxiliary proteins containing the same 
shared site leads to an n-fold increase in the concentration of the shared site and produces 
incorrect binding kinetics.  As shown previously [1, 2], the correct kinetics is obtained if only 
one of the binding reactions involving the shared site consumes or produces the binding partner. 
The auxiliary protein involved in this reaction is termed balance-accountable, whereas the 
remaining auxiliary proteins are termed balance-unaccountable.  The choice of the balance-
accountable auxiliary protein among the auxiliary proteins containing the shared site is arbitrary 
[1].  A detailed example that illustrates how this may be done manually in BioNetGen scripts 
using non-consumption tags and a manually-specified macro reduction is provided in 
Supplement 2. 
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This procedure, however, is insufficient when both reactants in a binding reaction contain 
shared sites. This is an important case to consider because many, if not most, RTKs dimerize.  
For this reason the current domain-oriented reduction module for BioNetGen performs mass 
balance corrections in a different way that does not involve the use of non-consumption tags in 
reaction rules, but rather applies corrections to the network of species and reactions generated by 
rule application, i.e., at the level of the net-file rather than at the level of the bngl-file (see 
Appendix).  
A detailed description of the implemented procedure is provided in Supplement 3, but the 
essential elements comprise steps 4(a)-4(c) in the algorithm summary provided below. 
(1) Analysis of reaction rules and patterns of the observables to determine the site 
dependence hierarchy for each protein, according to the algorithm described in 
Sec. 2.1 
(2) Replacement, where applicable, of progenitor proteins with the sets of auxiliary 
proteins, according to the algorithm described in Sec. 2.1. 
(3) Generation of “raw” or uncorrected network of species and reactions 
(accomplished in BioNetGen by the generate_network command).  
(4) Correction of the raw macro-network model. 
a. Complexes that contain two or more different auxiliary proteins derived 
from the same progenitor protein overload the macro-network with extra 
species. These species lead to the multiplication of the concentrations of 
unique sites, which leads to spurious effects. To eliminate this problem, all 
complexes that contain different auxiliary proteins derived from the same 
progenitor protein are removed from the list of species in the network and 
from the list of species corresponding to each observable. Reactions 
involving the removed species are also removed. 
b. To provide the correct mass balance for the partners of the shared sites, the 
module disables consumption or production of all species that bind to or 
dissociate from shared sites of balance-unaccountable auxiliary proteins.  
The current version of the domain-oriented reduction module treats homo-
dimerization as an exception to this rule, but does not handle the case of 
binding between shared sites (either direct or mediated via other proteins) of 
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different progenitor proteins (see Sec. 2.4 and Supplement 5 for more 
detail).  
c. Observables are corrected to eliminate species that contain balance-
unaccountable auxiliary proteins if their contribution to the observable has 
been also taken into account by species that contain balance-accountable 
proteins.  
A flowchart of the complete algorithm for domain-oriented model reduction that is implemented 
as a BioNetGen module is shown in Fig. 2. 
 
2.3 Numerical examples  
Numerical experiments illustrate the performance of automated model reduction methods for 
a set of several RTK signaling networks, including an EGFR-like network, in which ligand 
binding induces aggregation through receptor-receptor interactions [17, 27, 28] (see Fig. 1 and 
Supplement 1), and an FcεRI-like network (see Supplement 4), in which receptor aggregation is 
mediated by a bivalent ligand [29].  There are two versions of both models, one with two 
receptor tyrosine residues, r3 and r4, which upon phosphorylation can bind the adapter proteins, 
A and B, respectively (see Fig. 1), and one with an additional tyrosine, r3a, which also can bind A 
upon phosphorylation. 
Table 1 shows the extent of model reduction achieved by the domain-oriented method. 
Although the models presented here are small in scope, including only four proteins and a few 
reaction rules, the reduction method decreases the number of species and reactions, as well as 
time required for model generation, by orders of magnitude. Because even the reduced models 
contain tens, if not hundreds of species, and hundreds of reactions, manual (non-automatic) 
preparation of the reduced models seems impractical. The relative difference between results for 
the full and reduced models for the computed values of observables is less than 10-8 (the 
tolerance limit for the ODE integration), which confirms that the algorithm performs correctly 
and does introduce significant numerical errors into the integration (data not shown).  
 
2.4 Limitations 
Although these examples confirm the ability of the module to reduce the models by at 
least one or two orders of magnitude, the algorithm has limitations, which are summarized here 
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and described in detail in Supplement 5, where future extensions of the algorithm to address 
these limitations are also proposed. For each of the six cases discussed below, the possibility 
exists that current module may either fail to reduce a reducible model or may produce an 
incorrect reduced model (i.e., one whose simulation produces results that differ from those 
produced by the full model) if the model possesses certain features that trigger limitations in the 
current algorithm. To help users of the module avoid these outcomes, we provide tips, 
summarized in Table 2, for recognizing problematic model elements and adjusting module 
control parameters to avoid reducing parts of a model that cannot be correctly handled. We 
strongly suggest that, wherever possible, simulation results from reduced models obtained by the 
macro module be compared with results of an exact simulation to verify that the model has been 
correctly reduced. Although the limitations described here and elaborated in Supplements 3 and 
5 represent all limitations in the current algorithm of which we are presently aware, we do not 
have a proof that these are exhaustive, and it is thus possible that unforeseen instances of 
incorrect model reduction may occur. 
1.  Identical site names.  As mentioned in Section 2.1, the module assumes mutual 
dependence among sites with identical names.  Although this feature is necessary for the proper 
treatment of “bridging” events, in which two monomers are linked by a bivalent ligand, it also 
decreases the extent of model reduction when such bridging is not necessary. In the latter case, 
the user is advised to use unique names for each site on a molecule. 
2.  Implicit bonds.  In the current algorithm, each control relationship is detected using a 
single reaction rule that is taken separately from other rules.  As a result, the algorithm cannot 
identify control relationships arising from implicit binding relationships, such as in the BNGL 
expression A.B, which requires that proteins A and B be in the same complex but does not 
specify the mechanism of binding.  This limitation can be addressed at the user level by avoiding 
implicit dependencies in the model specification, although cases arise when this is not possible 
(see, e.g. [30]).  As detailed in Sec. 3 of Supplement 5, iterative processing of the rules could be 
used to resolve these control relationships. 
3.  Binding between shared and unique sites of the same auxiliary protein.  The current 
module incorrectly reduces models generating complexes with chains or loops of chemical bonds 
that link a unique site of an auxiliary protein to a shared site of the same protein or another 
instance of the same protein type.  The resulting reduced models have incorrect mass balances 
 13 
leading to incorrect simulation results for some observables. Automated handling of such cases 
would also require iterative processing of the rules.  To avoid the possibility of an error in model 
reduction, the user is advised to validate results of reduced model against full model wherever 
possible.  If a discrepancy occurs, the user can inspect the species list for the occurrence of 
complexes that link shared and unique sites.  If such species are found, the user must manually 
disable macro-reduction of the involved protein using the –nored option (see more details in 
Sec. 3 of Supplement 5). 
4. Control relationships between sites on different proteins.  The algorithm presented 
here only utilizes hierarchical control relationships within a single protein.  However, for models 
in which the state of one protein in a complex affects the transformations between the states of 
another protein in the same complex, the use of only within-protein control relationships may 
give an incorrect reduced model.  An example involving ordered phosphorylation of an adapter 
protein is illustrated in Fig. S5.2, and a bngl-file for the model is given in Supplement 6.  The 
current implementation does not detect control relationships between sites of different proteins, 
and, if such relationships exist in a model, the user is also advised to disable domain-oriented 
reduction (–nored option). In addition, incorrect model reduction can be detected by comparing 
time courses of the reduced and exact models, as shown in Fig. S5.3. 
5. Binding between shared sites of different proteins.  The algorithm does not identify 
reductions when auxiliary proteins from different progenitor proteins bind to each other through 
shared sites.  This case is important because when multi-site signaling proteins can form dimers, 
formation of the dimer frequently modulates the activity of sites within each protein—a 
prominent example being the ErbB family of RTKs [31, 32].  Allowing association of the 
auxiliary proteins of one progenitor protein with the auxiliary proteins of a different progenitor 
leads to a proliferation in the number of heterodimers.  The resulting problem of generating the 
correct mass balances for the binding partners of the progenitor proteins is not solved by the 
simple trick that works in the case of homodimerziation, in which the complexes containing 
different auxiliary proteins of the same progenitor protein are simply removed from the model. 
The avoid the possibility of errors the user is advised to use the –nored option for the proteins 
that undergo heterodimerization.  
6. Stochastic simulations.  A final limitation that applies to the BioNetGen 
implementation but not to the reduction algorithm per se is that simulations using kinetic Monte 
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Carlo methods such as Gillespie’s algorithm [33] with the macro-reduced reaction network will 
not be exact unless reactions involving binding and dissociation of shared sites are properly 
correlated.  The problem arises because in a discrete-event simulation, every time a binding or 
dissociation event occurs involving a shared site, the event should apply to all of the shared sites 
of the same molecule. In the macro model each of these events will be governed by a separate 
reaction (albeit with the same rate) and these will fire independently in a stochastic simulation, 
which de-correlates the levels of shared site occupancy for the auxiliary proteins sharing the site. 
(This problem does not apply to the ODE equations because all the events occur at the same rate 
and thus give the same values of site occupancy.) To retain the correct site occupancies, one 
could apply correlated Monte Carlo sampling [34], in which one event is used to trigger a change 
in state of the shared site of all n auxiliary proteins. This has not been done for the stochastic 
simulation algorithm in BioNetGen, but could be easily encoded in models exported in the 
Systems Biology Markup Language (see Appendix). 
 
3 Discussion 
The multiplicity of scaffold proteins involved in RTK signaling networks, their sites and 
states of these sites results in a combinatorial explosion of the number of possible states that 
involved proteins and their complexes may have. The interactions present in signal transduction 
systems may easily imply networks of possible species and reactions that are too large to 
simulate using standard methods for chemical kinetics. Recently, advances in kinetic Monte 
Carlo methodology that use particle-based event-driven simulations to avoid explicit generation 
of species and reactions appear to have broken to bottleneck caused by combinatorial complexity 
[35, 36]. ODEs, however, afford both computational and analytical advantages over stochastic 
methods and therefore methods for limiting the size of the ODE system implied by a set of 
biochemical interactions will continue to be important.  
A central result of our previous theoretical studies is that for many signaling networks, a 
microscopic picture of all possible species may be substituted with a more compact model that 
describes the network in terms of experimentally detectable states of separate domains [1, 2, 4, 
17]. The key features that allow such domain-oriented reduction are hierarchical control 
relationships between sites on proteins involved in signaling networks. 
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Based on these findings, we have developed a method for automatic domain-oriented 
reduction of signaling network models, which is implemented as a module in the software 
package BioNetGen. The reduction module takes a standard bngl-file as input and performs the 
following steps (see also Fig. 2). First, the module determines the control relationships between 
sites on protein molecules. Second, if possible, self-controlling subsets of sites are determined 
for each protein, and each reducible protein (progenitor protein) is substituted with a set of 
auxiliary proteins that have only the sites that belong to the self-controlling subsets. Third, the 
raw network model, which is described in terms of auxiliary proteins, is generated using 
BioNetGen. Finally, the raw model is corrected to provide correct mass balance for each species 
in the reduced model. 
The algorithm has been applied to several realistic examples involving aggregation of 
receptors with multiple binding and modification sites, and a high degree of model reduction was 
achieved, resulting in several orders of magnitude of in increased computational efficiency with 
no loss of accuracy (see Table 1). The method is fully automated, and the reduction module takes 
as input a standard BioNetGen input file including standard simulation commands (see Appendix 
and [19]). The only difference in output between a standard BioNetGen simulation and one run 
through the macro module is that species concentrations are reported only for the macro 
variables and not for the microscopic species. Time courses of observables generated by the full 
and reduced models will be identical, except in the cases noted in Sec. 2.4. Use of the module 
does not require the user to understand details of the algorithm, although the user is required to 
recognize the possible pitfalls described in Sec. 2.4 and in some cases to manually turn off 
reduction of problem proteins. Future work will focus on overcoming limitations to the 
applicability of the algorithm outlined in Sec. 2.4 and detailed in Supplement 5.   
Recently, a new model reduction technique based on modular analysis has been proposed 
that augments the domain-oriented approach used here, increasing the level of compression that 
can be attained at the cost of introducing some degree of error, which appears to be small for the 
cases examined so far [15].  At the present time, the method requires manual analysis and 
application, but its automation would appear to be a promising area for future development.   
  
4 Appendix: Overview of BioNetGen 
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BioNetGen provides a flexible language for the description of protein structure and protein 
interactions called the BioNetGen language (BNGL) [19] . A model specification in the bngl-
file may consist of five required elements:  parameters, species (also called seed 
species), reaction rules, observables, and actions. Parameters specify the 
kinetic rate constants, total protein concentrations and other fixed numerical properties of the 
model. Species describe molecules (including their sites and states of these sites) that are present 
at the start of network generation. For example, the species P(s1,s2~pY)defines a protein 
named P, which has two sites named s1 and s2, and specifies that the site s1 is free, and the site s2 
is in the state named pY (a mnemonic for phosphotyrosine) and also free.  
Reaction rules list the rules for building the biochemical network. For example, the 
reversible rule  
 A(b) + B(a,c) <-> A(b!1).B(a!1,c) k_on, k_off   
describes the binding and dissociation of molecules A and B, where the first reactant may be any 
species that contains the protein A whose site b is free, and the second reactant may be any 
species that contains the protein B whose sites a and c are both free.  The product of these 
reactions contains proteins A and B bound via b-site on A and a-site on B, as indicated by the 
exclamation mark followed by the number 1, which denotes a termination point for the bond 
labeled ‘1’. In this complex, the c-site on B is free and all other sites on A or B (that were 
specified in the species block) may be in any possible state. All the binding reactions 
generated by this reaction rule will have a second-order rate constant kon, and all dissociation 
reactions will have the first-order rate constant koff. Observables describe the sums over the 
concentrations of species sharing similar attributes, which correspond to the quantities that are 
measured in typical biological experiments. For example, the observable 
Molecules P_s2_phos P(s2~pY) 
defines the observable named P_s2_phos of type Molecules, which means a weighted sum 
over the species matching the pattern P(s2~pY), which finds instances of the protein P in 
which the site s2 is in state pY.  
 The last major element of a bngl-file is the set of actions, which are commands that 
operate on a model specification. Two basic commands are illustrated in the examples presented 
in Supplements 1, 2, and 6. The generate_network command automatically generates the 
set  of all feasible species and reactions by iterative application of the rules to the initial set of 
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species. The resulting network can be written either in the BioNetGen-specific format (net-file) 
or exported in the Systems Biology Markup Language [37], which can be imported by a large 
number of other simulation and analysis tools. The simulate_ode command performs and 
ODE-based simulation of the network over a specified time period with results reported at 
specified time points. Additional commands and details of BNGL syntax can be found in [19]. 
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Tables 
 
Table 1. Quantification of the network reduction achieved by the domain-oriented 
reduction method.1 
 Total number 
of species in 
the full / 
reduced 
model 
Total number 
of reactions in 
the full / 
reduced 
model 
CPU time for 
network generation, 
of the full / reduced 
model (s) 
CPU time for 
ODE 
integration of 
the full / 
reduced model 
(s) 
Receptor 
with 2 
tyrosine 
residues 
708/108 7432/534 51.6/8.45 1.45/0.22 EGFR-like 
network  
 
Receptor 
with 3 
tyrosine 
residues 
6000/135 81364/642 662.0/12.0 12.58/0.76 
Receptor 
with 2 
tyrosine 
residues 
213/48  2230/198 14.2/3.87 0.47/0.15 FcεRI-like 
network 
Receptor 
with 3 
tyrosine 
residues 
1599/60 22990/240 182.4/6.02 3.58/0.12 
1Computed using BioNetGen 2.0.41 running on Pentium® 4 CPU 2.80 GHz with 1 GB RAM . 
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Table 2. Overview of limitations in the current version of the domain-oriented reduction 
module.  See corresponding section of Supplement 5 for further discussion of each 
limitation.  
Limitation Model properties that 
trigger this limitation  
How the module 
processes this case 
How to avoid the 
problem 
Plans for future 
handling  
1. Identical 
site names 
Proteins containing two or 
more sites that have the same 
name. 
Sites with identical 
names are assumed 
mutually dependent.  
Make site names 
unique.  
None. 
2. Implicit 
bonds 
include / exclude 
directives in reaction rules. 
Implicit bonds in reaction 
rules or observables. 
Implicit bonds are not 
considered in control 
relationships.  
Remove include / 
exclude directives 
and implicit bonds from 
the model. 
Identification of 
control relationships 
through iterative 
processing  
3. Binding 
between 
shared and 
unique sites of 
the same 
auxiliary 
protein 
Complexes that contain a 
bond or a chain of bonds that 
connects the shared and 
unique sites of one auxiliary 
protein or two auxiliary 
proteins of the same type.  
Generates reduced 
models with incorrect 
mass-balance. 
Inspect species list for 
occurrence of such 
complexes.  Validate 
results of reduced 
model against full 
model. 
Automated detection 
of offending 
complexes. 
4. Control 
relationships 
between sites 
on different 
proteins 
State of protein P influences 
transformation between 
states of protein Q within a 
complex. 
 Generation of 
incorrect reduced 
models for the 
observables that 
contain Q. 
Disable reduction of P 
by using the command-
line option “-nored 
P” 
Unknown. 
5. Binding 
between 
shared sites of 
different 
proteins 
Binding of reducible proteins 
through shared sites, i.e., 
heterodimerization.  
Generation of 
incorrect reduced 
models. 
Disable reduction of 
proteins involved in 
heterodimerization 
using –nored option. 
Unknown. 
6. Stochastic 
simulations 
Simulation of reduced 
models using kinetic Monte 
Carlo methods, e.g., 
Gillespie algorithm.  
Levels of shared site 
occupancy are 
decoupled among 
auxiliary proteins. 
Validate results of 
reduced model against 
full model to estimate 
size of errors. 
Correlated Monte 
Carlo sampling [34]. 
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Figures 
 
 
Fig. 1. Multiplicity of the states of receptor and receptor-adapter complexes.  The state of the 
receptor molecule R is characterized by a vector (r1, r2, r3, r4), where r1 stands for the ligand (L)-binding 
site, r2 depicts the dimerization site, and r3 and r4 specify the state of docking sites for adapter proteins. 
The adapter protein B is a scaffold that possesses three sites (site b1 for binding to the receptor, and 
tyrosine residues b2 and b3).  
 
 
 
Fig. 2. A flowchart of operations for the domain-oriented reduction algorithm. 
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Supplemental Materials 
 
Supplement 1.  A BNGL script that describes the EGFR-like network, depicted in Fig. 1. 
Supplement 2.  A BNGL script that manually specifies the reduction of a model for a 
kinase K that binds and phosphorylates a protein Q at multiple sites. 
Supplement 3. Algorithms for processing the net-file for the reduced model. 
Supplement 4. A BNGL script that describes the FcεRI-like network. 
Supplement 5.  Limitations of the domain-oriented reduction method. 
Supplement 6. A BNGL script for ordered phosphorylation of a substrate. 
